COVID-19/Flu Rapid Test | Hospimedica Expo
Summary
|
Products
CHEMBIO DIAGNOSTIC SYSTEMS
COVID-19/Flu Rapid Test  
Model: Status COVID-19/Flu
Quick Inquiry
Description
The Status COVID-19/Flu is the only FDA EUA visual read rapid test for the simultaneous detection and differential diagnosis of SARS-CoV-2, Influenza Type A & Influenza Type B Antigen in nasopharyngeal swab specimens.

Request Information
Request Price/Quote

Features
PERFORMANCE CHARACTERISTICS
• COVID-19: Sensitivity 93.9%; Specificity 100%
• Flu A: Sensitivity 91.4%; Specificity 95.7%
• Flu B: Sensitivity 87.6%; Specificity 95.9%

EFFICIENT
• 3 tests in 1 consolidates and speeds workflow
• Fast results in only 15 minutes
• Easy to run with no pipetting and premeasured buffer
• Room temperature storage

CONVENIENT
• Generate revenue by processing results in-house
• Visual read removes capital equipment analyzer costs
• Collect 1 sample for both COVID-19, Flu A and Flu B
• Simplified “Go Live” with Chembio’s enhanced onsite training program
Specification
• Time to Results: 15 Minutes
• Sample: Nasopharyngeal Swab Specimen
• Reader: No analyzer required; Visual Read
• Storage Conditions: 2 to 30°C (36 to 86°F)
• Method: Lateral Flow

Request Information
Request Price/Quote